Stock Events

Stock Events

Aclaris Therapeutics (ACRS) Q2 2026 Earnings

7MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-0.16

-0.15

-0.13

-0.12

Details

Expected EPS

-0.157778

Actual EPS

-0.15

Surprise EPS

0.01

Surprise Percent

+4.93%

Description

Aclaris Therapeutics (ACRS) has reported earnings of -0.15 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.